A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation
This post hoc mortality analysis of phase 3 data suggests that letermovir prophylaxis reduced all-cause mortality versus placebo in cytomegalovirus (CMV)-seropo
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
Clinical infectious diseases
Year: 2020, Jahrgang: 70, Heft: 8, Pages: 1525-1533 |
| ISSN: | 1537-6591 |
| DOI: | 10.1093/cid/ciz490 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/cid/ciz490 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/cid/article/70/8/1525/5513132 |
| Verfasserangaben: | Per Ljungman, Michael Schmitt, Francisco M. Marty, Johan Maertens, Roy F. Chemaly, Nicholas A. Kartsonis, Joan R. Butterton, Hong Wan, Valerie L. Teal, Kendra Sarratt, Yoshihiko Murata, Randi Y. Leavitt, and Cyrus Badshah |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1735467529 | ||
| 003 | DE-627 | ||
| 005 | 20230427161425.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201013s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciz490 |2 doi | |
| 035 | |a (DE-627)1735467529 | ||
| 035 | |a (DE-599)KXP1735467529 | ||
| 035 | |a (OCoLC)1341371086 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ljungman, Per |d 1950- |e VerfasserIn |0 (DE-588)120777698X |0 (DE-627)169410253X |4 aut | |
| 245 | 1 | 2 | |a A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation |c Per Ljungman, Michael Schmitt, Francisco M. Marty, Johan Maertens, Roy F. Chemaly, Nicholas A. Kartsonis, Joan R. Butterton, Hong Wan, Valerie L. Teal, Kendra Sarratt, Yoshihiko Murata, Randi Y. Leavitt, and Cyrus Badshah |
| 264 | 1 | |c 2020 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online June 8, 2019 | ||
| 500 | |a Gesehen am 13.10.2020 | ||
| 520 | |a This post hoc mortality analysis of phase 3 data suggests that letermovir prophylaxis reduced all-cause mortality versus placebo in cytomegalovirus (CMV)-seropo | ||
| 700 | 1 | |a Schmitt, Michael |d 1966- |e VerfasserIn |0 (DE-588)133177173 |0 (DE-627)538000600 |0 (DE-576)299672921 |4 aut | |
| 700 | 1 | |a Marty, Francisco M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Maertens, Johan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chemaly, Roy F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kartsonis, Nicholas A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Butterton, Joan R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wan, Hong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teal, Valerie L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sarratt, Kendra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Murata, Yoshihiko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leavitt, Randi Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Badshah, Cyrus |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases |d Oxford : Oxford Journals, 1992 |g 70(2020), 8, Seite 1525-1533 |h Online-Ressource |w (DE-627)320418308 |w (DE-600)2002229-3 |w (DE-576)090881834 |x 1537-6591 |7 nnas |a A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation |
| 773 | 1 | 8 | |g volume:70 |g year:2020 |g number:8 |g pages:1525-1533 |g extent:9 |a A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation |
| 856 | 4 | 0 | |u https://doi.org/10.1093/cid/ciz490 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/cid/article/70/8/1525/5513132 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201013 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 133177173 |a Schmitt, Michael |m 133177173:Schmitt, Michael |d 910000 |d 910100 |e 910000PS133177173 |e 910100PS133177173 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1735467529 |e 3779726246 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1735467529","name":{"displayForm":["Per Ljungman, Michael Schmitt, Francisco M. Marty, Johan Maertens, Roy F. Chemaly, Nicholas A. Kartsonis, Joan R. Butterton, Hong Wan, Valerie L. Teal, Kendra Sarratt, Yoshihiko Murata, Randi Y. Leavitt, and Cyrus Badshah"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"2020"}],"language":["eng"],"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.1093/cid/ciz490"],"eki":["1735467529"]},"relHost":[{"language":["eng"],"disp":"A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantationClinical infectious diseases","id":{"issn":["1537-6591"],"zdb":["2002229-3"],"eki":["320418308"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320418308","pubHistory":["14.1992 -"],"part":{"text":"70(2020), 8, Seite 1525-1533","issue":"8","pages":"1525-1533","year":"2020","volume":"70","extent":"9"},"origin":[{"publisher":"Oxford Journals ; Univ. of Chicago Press, Journals Division","dateIssuedKey":"1992","dateIssuedDisp":"1992-","publisherPlace":"Oxford ; Chicago, Ill."}],"title":[{"title":"Clinical infectious diseases","title_sort":"Clinical infectious diseases","subtitle":"electronic edition"}],"note":["Gesehen am 31.07.2023"]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Ljungman, Per","family":"Ljungman","given":"Per","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Michael","role":"aut","roleDisplay":"VerfasserIn","display":"Schmitt, Michael","family":"Schmitt"},{"family":"Marty","display":"Marty, Francisco M.","role":"aut","roleDisplay":"VerfasserIn","given":"Francisco M."},{"roleDisplay":"VerfasserIn","role":"aut","given":"Johan","family":"Maertens","display":"Maertens, Johan"},{"display":"Chemaly, Roy F.","family":"Chemaly","given":"Roy F.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Nicholas A.","family":"Kartsonis","display":"Kartsonis, Nicholas A."},{"roleDisplay":"VerfasserIn","role":"aut","given":"Joan R.","family":"Butterton","display":"Butterton, Joan R."},{"family":"Wan","display":"Wan, Hong","role":"aut","roleDisplay":"VerfasserIn","given":"Hong"},{"family":"Teal","display":"Teal, Valerie L.","role":"aut","roleDisplay":"VerfasserIn","given":"Valerie L."},{"family":"Sarratt","display":"Sarratt, Kendra","role":"aut","roleDisplay":"VerfasserIn","given":"Kendra"},{"given":"Yoshihiko","roleDisplay":"VerfasserIn","role":"aut","display":"Murata, Yoshihiko","family":"Murata"},{"family":"Leavitt","display":"Leavitt, Randi Y.","role":"aut","roleDisplay":"VerfasserIn","given":"Randi Y."},{"given":"Cyrus","roleDisplay":"VerfasserIn","role":"aut","display":"Badshah, Cyrus","family":"Badshah"}],"title":[{"title":"A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation","title_sort":"mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation"}],"note":["Published online June 8, 2019","Gesehen am 13.10.2020"]} | ||
| SRT | |a LJUNGMANPEMORTALITYA2020 | ||